Importantly, Tat will be produced and released by residually infected CNS cells even when new infection is limited by cART (Johnson et al. 2013), suggesting its importance in determining the stability of CNS cell populations and motor and cognitive health during chronic infection. The gene discussed is TAT; the disease is infection.